Sinch Reaches Milestone of 1 billion RCS Business Messages Delivered Worldwide
STOCKHOLM,Nov. 20,2024--Sinch(Sinch AB (publ)) (XSTO: SINCH),which is pioneering the way the world communicates through its Customer Communications Cloud,today announced that during 2024,the company h
Complete Genomics announces mpox virus amplicon sequencing panel at AMP
VANCOUVER,BC,Nov. 21,2024--Complete Genomics,a San Jose,Calif.-based genomic sequencer manufacturer,today announced at the 2024 Association for Molecular Pathology (AMP) Annual Meeting & Expo the
LOUVAIN-LA-NEUVE,Belgium,Nov. 20,2024-- Odoo S.A.,a leading provider of integrated business software,today announced a €500 million transactionled by CapitalG and Sequoia Capital,with participation
Aetina Debuts at SC24 With NVIDIA MGX™ Server for Enterprise Edge AI
TAIPEI,Nov. 20,2024--Aetina,a subsidiary of the Innodisk Group and an expert in edge AI solutions,is pleasedto announce its debut at Supercomputing (SC24) in Atlanta,Georgia,showcasing the innovative
United Imaging Installs Another Flagship uMR OMEGA®, in New Mexico
X-Ray Associates of New Mexico (XRANM),with their motto "We Don\'t Follow. We Lead.",took decisive action to have the 75 cm 3T MRI scanner installed and clinically operational within ten mon
Toss Securities Launches Dedicated Research Center for Retail Investors Focusing on US Stock Markets
Aims to deliver high-quality reports accessible to all Toss Securities users as a means to empower retail investors to invest in global capital markets
Travel is one of the highest credit card spend categories for Asia Pacific survey respondents,accounting for almost a third (27%) of annual expenditure.
SINGAPORE,Nov. 19,2024-- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU),today announced that the English version of the emotional short drama When My Son Choose Hi
Noah to Host Corporate Open Day on December 6, 2024, in Hong Kong
SHANGHAI,Nov. 19,2024--Noah Holdings Limited(the "Company" or "Noah") (NYSE: NOAH and HKEX: 6686),a leading and pioneer wealth management service provider offering comprehensive ad
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Highlights: Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS)